Skip to main content

precision medicine Archives

Achilles’ heel for kidney cancer

Feb. 28, 2019—The discovery that kidney cells with mutations in a certain gene are sensitive to therapies called PI3K inhibitors opens new opportunities for applying precision medicine to cancer treatment.

Read more


Investigators map genomic landscape of very rare cancer

Feb. 28, 2019—A team of Vanderbilt researchers mapped out the genomic landscape of a metastatic malignant proliferating tricholemmal tumor and identified a targeted treatment for this very rare cancer.

Read more


Grant supports novel imaging initiative to enhance cancer care

Jan. 31, 2019—A Vanderbilt initiative to develop predictive imaging technologies that clinicians can use to better match patients with personalized care has received National Cancer Institute (NCI) funding.

Read more


Ethics study explores precision medicine’s risks, rewards

Nov. 29, 2018—Precision medicine research — which involves the consolidation of massive amounts of complex data and the widespread sharing of those data for a variety of research studies — offers the prospect of both benefit and harm.

Read more


Event set to launch ‘All of Us’ personalized medicine initiative

May. 3, 2018—The All of Us Research Program, which aims to accelerate the prevention and treatment of illness through precision medicine with the help of a million or more research participants across the United States, officially opens for national enrollment Sunday, May 6.

Read more


Wilkins takes key role in national ‘All of Us’ precision medicine effort

Apr. 26, 2018—Consuelo Wilkins, MD, MSCI, has played a major role in the development of the national All of Us Research Program, an ambitious effort led by the National Institutes of Health (NIH) to accelerate the prevention and treatment of illness through precision medicine.

Read more


Precision medicine discussion

Oct. 26, 2017—Consuelo Wilkins, M.D., MSCI, and Joshua Denny, M.D., M.S., discussed the potential of precision medicine during their recent Flexner Discovery Lecture.

Read more


Denny, Wilkins to discuss precision medicine at next Discovery Lecture

Oct. 5, 2017—Joshua Denny, M.D., M.S., and Consuelo Wilkins, M.D., MSCI, will discuss the potential of “precision medicine” during the next Vanderbilt Cutting-Edge Discovery Lecture on Thursday, Oct. 12.

Read more


VUMC chosen for leadership role in NIH Precision Medicine Initiative Cohort Program

Jul. 7, 2016—Vanderbilt University Medical Center has been chosen by the National Institutes of Health to be a leader in a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people. The NIH will provide $71.6 million over five years to VUMC, making this the largest research grant the Medical Center has ever received from any source.

Read more


VUMC chosen for leadership role in NIH Precision Medicine Initiative Cohort Program

Jul. 7, 2016—Vanderbilt University Medical Center (VUMC) has been chosen by the National Institutes of Health (NIH) to be the Data and Research Support Center for the Precision Medicine Initiative Cohort Program, a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people, federal officials have announced.

Read more


NIH awards $11.6 million grant to Vanderbilt, Miami and Meharry for new center to study precision medicine and health disparities

May. 25, 2016—Researchers at Vanderbilt University Medical Center (VUMC), the University of Miami and Meharry Medical College were recently awarded a five-year, $11.6 million grant to launch a new center that will enable research using precision medicine to eradicate health disparities, specifically those among African-Americans and Latinos.

Read more


Study looks at doctors’ response to genetic testing

Mar. 31, 2016—A new clinical implementation study from Vanderbilt University Medical Center measures how physicians have responded to the introduction of routine genetic testing to predict patient response to the commonly prescribed antiplatelet drug clopidogrel.

Read more


Recent Stories from VUMC News and Communications Publications

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Hope

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Vanderbilt Nurse

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

Vanderbilt Medicine

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

One hundred years ago, multiple “waves” of a deadly flu swept across the world.

Vanderbilt Medicine

One hundred years ago, multiple “waves” of a deadly flu swept across the world.

more